Thomas C. Chesterman

Thomas C. Chesterman discloses dealings in 2 companies, chiefly SenesTech, Inc. and Bionovo Inc. Over a trading history stretching from 23 March 2011 to 17 July 2017, the count stands at 13 filings.

Both buying and selling appear: 1 purchase worth €4,296, against 6 sales worth €57k. Netting one side against the other leaves €53k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 3 share grants and 3 option exercises. Since January 2017: no purchases and 6 sales on the market.

The newest entry dates from 20 July 2017: an open-market sale of €1,764, in SenesTech, Inc. The clock since the last published purchase (24 March 2011) now reads 5,692 days. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.